Glutathione as a depigmenting agent: An overview

International Journal of Cosmetic Science

Volumn 27, Issue 3, 2005, Pages 147-153

  Villarama, Clarissa D ^a,b   Maibach, H I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

Depigmentation; Glutathione; Phaeomelanogenesis; Skin lightening

Indexed keywords

4 TERT BUTYL CATECHOL; ACETYLCYSTEINE; BUTHIONINE SULFOXIMINE; CATECHOL DERIVATIVE; COSMETIC; CYSTAMINE; CYSTEINE; DEPIGMENTING AGENT; FREE RADICAL; GAMMA GLUTAMYLTRANSFERASE; GLUTAMIC ACID; GLUTATHIONE; GLUTATHIONE REDUCTASE; GLYCINE; HYDROQUINONE; MELANIN; MONOPHENOL MONOOXYGENASE; N ACETYL 4 S CYSTEAMINYLPHENOL; PHENOL DERIVATIVE; PHEOMELANIN; RETINOIC ACID; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; CELL PROTECTION; DEPIGMENTATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ESTHETICS; GLUTATHIONE METABOLISM; MELANOCYTE; MELANOGENESIS; NONHUMAN; REVIEW; SKIN PIGMENTATION;

EID: 18944390367     PISSN: 01425463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-2494.2005.00235.x     Document Type: Review

References (44)

1. Prota, G. Recent advances in the chemistry of melanogenesis in mammals. J. Invest. Dermatol. 75, 122-127 (1980).
2. Meister, A. and Tate, S. Glutathione and related gamma-glutamyl compounds: biosynthesis and utilization. Annu. Rev. Biochem. 45, 559-604 (1969).
3. Halprin, K. and Okhawara, A. Glutathione and human pigmentation. Arch. Derm. (Stockh) 94, 355-357 (1966).
4. Figge, F. and Allen, E. Release of glutathione inhibition of melanin formation by esterone. Endocrinology 29, 262-266 (1944).
5. Potterf, S.B., Benathan, M., Sakai C., Furumura M. and Hearing V.J. Melanin precursor regulation by agouti and MSH: roles of thiol-containing compounds. Pigment Cell Res. 10, 331-332 (1997).
6. Wheeler, L., Aswad, A., Connor, M. and Lowe, N. Depletion of cutaneous glutathione and the induction of inflammation by 8-methoxypsoralen plus UVA radiation. J. Invest. Dermatol. 87, 658-662 (1986).
7. Rothman, S., Krysa H.F. and Smiljanic, A. Inhibitory action of human epidermis on melanin formation. Proc. Soc. Exp. Biol. Med. 62, 208-209 (1946).
8. Flesch, P. Inhibitory action of extracts of mammalian skin on pigment formation. Proc. Soc. Exp. Biol. Med. 70, 136-140 (1949).
9. Benedetto, J.-P., Ortonne, J.-P. and Voulout, C. Role of thiol compounds in mammalian melanin pigmentation. I. Reduced and oxidized glutathione. J. Invest. Dermatol. 77, 402-405 (1981).
10. Sanchez-Ferrer, A., Rodriguez-Lopez, J.N. and Garcia-Carmona, F. Tyrosinase: a comprehensive review of its mechanism. Biochim. Biophys. Acta 1247, 1-11 (1995).
11. Lerner, A., Fitzpatrick, E., Calkins, E. and Summerson, W. Mammalian tyrosinase. The relationship of copper to enzymatic activity. J. Biol. Chem. 187, 793-802 (1950).
12. Reish, O., Townsend, D., Berry, S.A., Tsai, M.Y. and King, R.A. Tyrosinase inhibition due to interaction of homocyst(e)ine with copper: the mechanism for reversible hypopigmentation in homocystinuria due to cystathionine beta-synthetase deficiency. Am. J. Hum. Gen. 57, 127-132 (1995).
13. Jergil, B., Lindblah, C., Rorsman, H. and Rosengren, E. Inactivation of human tyrosinase by cysteine: protection by DOPA and tyrosine. Acta Derm. Venereol. (Stockh) 64, 155-157 (1984).
14. Jara, J.R., Aroca, P., Solano, F., Martinez, J.H. and Lozano, J.A. The role of sulfhydyrl compound in mammalian melanogenesis: the effect of cysteine and glutathione upon tyrosinase and the intermediates of the pathway. Biochim. Biophys. Acta 967, 296-303 (1988).
15. Seiji, M., Yoshida, T., Itakura, H. and Irimajiri, T. Inhibition of melanin formation by sulfhydryl compounds. J. Invest. Dermatol. 52, 280-286 (1968).
16. Rorsman, H., Albertsson, E., Edholm, L. et al. Thiols in the melanocyte. Pigment Cell Res. Suppl. 1, 54-60 (1987).
17. Iwata, K. and Takeuchi, T. Granule-bound tyrosinase: solubilization and its relation to the soluble form of tyrosinase. J. Invest. Dermatol. 66, 88-92 (1977).
18. Korner, A. and Pawelek, J. Mammalian tyrosinase catalized three reactions in melanin biosynthesis. Science 217, 1163-1165 (1982).
19. Imokawa, G. Analysis of initial melanogenesis including tyrosinase transfer and melanosome differentiation through interrupted melanization by glutathione. J. Invest. Dermatol. 93, 100-107 (1989).
20. Yamamamura, T., Onishi, J. and Nishimyama, T. Antimelanogenic activity of hydrocoumarins in cultured normal human melanocytes by stimulating intracellular glutathione synthesis. Arch. Dermatol. Res. 294, 349-354 (2002).
21. del Marmol, B., Solano, F., Sels, A. et al. Glutathione depletion increases tyrosinase activity in human melanoma cells. J. Invest. Dermatol. 101, 841-844 (1993).
22. Karg, E., Odh, G., Wittbjer, A., Rosengren, E. and Rorsman, H. Hydrogen peroxide as an inducer of elevated tyrosinase level in melanoma cells. J. Invest. Dermatol. 100, 209s-213s (1993).
23. Ito, S. High-performance liquid chromatography (HPLC) analysis of eu- and pheomelanin in melanogenesis control. J. Invest. Dermatol. 100, 166S-171S (1993).
24. Benethan, M. and Labidi, F. formation and its regulation by glutathione in normal epidermal melanocytes. Arch. Dermatol. Res. 288, 697-702 (1996).
25. Benathan, M. cysteinyldopa formation by tyrosinase activity and intracellular thiols in human melanoma cells. Melanoma Res. 6, 183-189 (1996).
26. Carstam, R., Edner, C., Hansson, C. et al. Metaboism of 5-S-glutathionyldopa. Acta Derm. Venereol. 126S (1986).
27. Miranda, M., di Ilio, C., Bonfifli, A. et al. A study on the in vitro interaction between tyrosinase and glutathione-S-transferase. Biochim. Biophys. Acta 913, 396-394 (1987).
28. Prota, G. Regulatory mechanisms of melanogenesis: beyond the tyrosinase concept. J. Invest. Dermatol. 100, 156S-161S (1993).
29. Benathan, M., Virador, V., Minao, F. et al. Co-regulation of melanin precursors and tyrosinase in human pigment cells: roles of cysteine and glutathione. Cell Mol. Biol. 45, 981-990 (1999).
30. Ozeki, H., Ito, S., Wakamatsu, K. and Ishiguro, I. Chemical characterization of pheomelanogenesis starting from dihydroxyphenylalanine or tyrosine and cysteine. Effects of tyrosinase and cysteine concentrations and reaction time. Biochim. Biophys. Acta 1336, 539-548 (1997).
31. Jimbow, K., Obata, H., Pathak, M.A. and Fitzpatrick, T.B. Mechanism of depigmentation by hydroquinone. J. Invest. Dermatol. 62, 436-449 (1974).
32. Tyrrell, R. and Pidoux, M. Correlation between endogenous glutathione content and sensitivity of cultures human skin cells to radiation at defined wavelength in the solar ultraviolet range. Photochem. Photobiol. 47, 561-564 (1986).
33. Hanada, K., Grange, RW, and Connor, MJ. Effect of glutathione depletion on sunburn cell formation in the hairless mouse. J. Invest. Dermatol. 96, 838-840 (1991).
34. Yonemoto, K., Gelin, G., Epstein, W. and Fukuyama, K. Reduction in eumelanin by the activation of glutathione reductase and gamma-glutamyl transpeptidase after exposure to a depigmenting chemical. J. Biochem. Pharmacol. 32, 1379-1382 (1983).
35. Bolognia, J., Sodi, S., Osber, M. and Pawelek, J. Enhancement of the depigmenting effect of hydroquinone by cystamine and buthionine sulfoximine. Br. J. Dermatol. 133, 349-357 (1995).
36. Alena, F., Dixon, W., Thomas, P. and Jimbow, K. Glutathione plays a key role in the depigmenting and melanocytotoxic action of N-acetyl-4-S- cysteaminylphenol in black and yellow hair follicles. J. Invest. Dermatol. 104, 792-797 (1995).
37. Kasraee, B., Handjani, F. and Aslani, F. Enhancement of the depigmenting effect of hydroquinone and 4-hydroxyanisole by all-trans-retinoic acid (tretinoin): the impairment of glutathione-dependent cytoprotection? Dermatology 206, 289-291 (2003).
38. Griffith, O.W. and Meister, A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-R-butyl homocysteine sulfoximine). J. Biol. Chem. 254, 7558-7560 (1979).
39. Griffith, O., Larson, A. and Meister, A. Inhibition of gamma-glutamyl cysteine synthetase by cystamine: an approach to a therapy of 5-oxoprolinuria(pyroglutamic aciduria). Biochem. Biophys. Res. Commun. 79, 919-925 (1977).
40. Jimbow, K. N-acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of patients with melasma. Arch. Dermatol. 127, 1528-1534 (1991).
41. Alena, F., Iwashina, T., Gili, A. and Jimbow, K. Selective in vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in vitro and in vivo antimelanoma effect by combination of buthionine sulfoximine. Cancer Res. 54, 2661-2666 (1994).
42. Teixeira, C., Shapiro, I., Hatori, M., Rajpurohit, R. and Koch, C. Retinoic acid modulation of glutathione and cysteine metabolism in chondrocytes. Biochem J. 314, 21-26 (1996).
43. Kligman, A. and Willis, I. A new formula for depigmenting human skin. Arch. Dermatol. 111, 40-48 (1975).
44. Gawkrodger, D.J., Cork, M.J. and Bleehen, S.S. Occupational vitiligo and contact sensitivity to paratertiary butyl catechol. Contact Dermatitis 25, 200-201 (1991).